-
Mashup Score: 0
The Supreme Court blocked Purdue Pharma’s bankruptcy proceedings Thursday in a decision that also halts the deal granting immunity to the Sackler family. The Sackler family owned and operated Purdue Pharma, LLP, which manufactured OxyContin and marketed the drug with a misleading claim that the drug was less addictive. Purdue Pharma pleaded guilty to federal criminal charges for its role in
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Opinion | I Am a Physician Face of Affirmative Action - 10 month(s) ago
The Supreme Court’s ruling hurts, but still I have hope
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
"I am a face of #affirmativeaction." According to @jbullockruns, last week's #SupremeCourt ruling has consequences not only for diverse #medicalschool applicants, but also for the well-being of patients. https://t.co/ZyCDfpsN6q
-
-
Mashup Score: 2Who will be tomorrow's doctors? - 10 month(s) ago
If past state rulings are any indication, a recent Supreme Court decision will lead to changes in who becomes a doctor.
Categories: Latest Headlines, PulmonologyTweet-
What should we expect with medical school admissions following the most recent #SupremeCourt ruling on #AffirmativeAction? A study of past state-level bans on race-conscious admissions by @meddly @AnupamBJena @UREssien is highly informative https://t.co/DN2ZJkJp3Z https://t.co/W67D3wkarc
-
-
Mashup Score: 3Supreme Court outlaws RACE as a factor in college admissions - 10 month(s) ago
The Supreme Court has outlawed the consideration of race as a factor in college admissions.
Source: Mail OnlineCategories: Healthcare Professionals, Latest HeadlinesTweet-
#SupremeCourt outlaws RACE as a factor in college admissions in major affirmative action ruling: Justices vote 6-3 to rule Harvard and UNC programs unconstitutional https://t.co/HqM4KyCz2W
-
-
Mashup Score: 0Supreme Court strikes down use of affirmative action, a blow to efforts to diversify medical schools - 10 month(s) ago
The U.S. Supreme Court struck down the use of affirmative action, ruling that it is unconstitutional for colleges, universities — and professional schools for law, medicine, and nursing — to consider race as one factor in deciding who they will admit.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
#SupremeCourt strikes down use of #AffirmativeAction, a blow to efforts to #DiversifyMedicalSchools https://t.co/eIWTWr05Tc @STATNews https://t.co/O9em3B5z9i
-
-
Mashup Score: 0A Year Later, Doctors Feel Impact of Dobbs Decision 'Every Single Day' - 10 month(s) ago
‘Sometimes, I feel that I am not able to fulfill the Hippocratic Oath’
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
It's been one year since the #SupremeCourt overruled #RoevWade. @rachrobertson__ spoke to doctors across the country who feel the direct impact of the #DobbsDecision "every single day." @DrMelissaSimon @mcneillymed @DrDGrossman @DavidNHackney @ANSIRH https://t.co/xl6Nz5o54l
-
-
Mashup Score: 0Supreme Court rules against Amgen in closely watched case over scope of patent claims - 11 month(s) ago
U.S. Supreme Court has ruled against Amgen in a patent case that had the entire pharmaceutical on edge.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Supreme Court rules against Amgen in closely watched patent case Really nice @pharmalot piece https://t.co/KuErFaqEIB
-
U.S. Supreme Court rules against Amgen in closely watched case over scope of patent claims.. https://t.co/LaiKhR8br0 #pharma #biotech #SCOTUS #SupremeCourt #patents #cholesterol $AMGN $REGN $SNY
-
-
Mashup Score: 0U.S. Supreme Court declines to hear 'skinny labeling' case with implications for generic drug access - 11 month(s) ago
“A lot of generic companies use this pathway to get on the market. If we don’t have that, it could end up costing consumers untold dollars.”
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
U.S. Supreme Court declines to hear ‘skinny labeling’ case with implications for generic drug access.. https://t.co/YAADYtZXYf #pharma #generics #SCOTUS #SupremeCourt $GSK $TEVA
-
-
Mashup Score: 0Legal Experts on What's Next for Mifepristone - 12 month(s) ago
Case returns to Fifth Circuit Court, then what?
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Legal experts clashed on the significance of last week's #SupremeCourt decision to allow the continued sale of #mifepristone (#Mifeprex) while the case plays out in lower courts. @LawrenceGostin @oneillinstitute @MedPagePolicy https://t.co/U9ju4GxQiu
-
-
Mashup Score: 1
High court reviews lower court ruling focused on ‘subjective intent’
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The #SupremeCourt heard oral arguments this week on whether major #pharmacies illegally overbilled #Medicare and #Medicaid for prescription drugs, a case that could weaken a key law the federal government uses to stamp out fraud. @MedPagePolicy #TwitteRx https://t.co/qjaMfX6V6X
-
A court ruling previously protected the Sackler family from #opioid lawsuits in exchange for a 💲6 billion contribution to Purdue Pharma’s bankruptcy plan, but the #SupremeCourt recently blocked that deal. 🔗 Read more: https://t.co/TvxGemGr80